K. Gartner

Clinical infections in the noninstitutionalized geriatric age group: methods utilized and incidence of infections. The Pittsburgh Good Health Study.

L. Kuller, S. Kelsey, G. Bochicchio, 1995, American journal of epidemiology.

Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

Ana C. Matos, C. Königs, C. Giaquinto, 2022, The lancet. HIV.

Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial

Ana C. Matos, C. Königs, J. Seeley, 2022, The lancet. HIV.

Clinical, Virological and Immunological Subphenotypes in a Cohort of Early Treated HIV-Infected Children

C. Giaquinto, P. Palma, D. Sauce, 2022, Frontiers in Immunology.